The Trump Administration: Year One

A Faegre Baker Daniels Reference Guide

Businesses and other entities with interests before the federal government should always be monitoring Washington, D.C., to manage risk and identify opportunities — especially in a time of change. As the Trump administration and 115th U.S. Congress continue to roll out an aggressive legislative agenda, Faegre Baker Daniels’ lawyers and our colleagues at Faegre Baker Daniels Consulting are committed to helping clients understand and proactively manage regulatory decisions that will impact their businesses.

In this space, FaegreBD consultants and lawyers will share timely insights and industry-focused resources to help companies stay ahead of the curve on issues related to federal government activity.

Latest Updates

As Feds Talk, States Act: A Survey of Recent State Actions to Rein in Drug Prices
While Congress and the White House continue to make statements about the need to rein in drug costs, states are taking steps to remake practices perceived as abetting spiraling drug costs.

FDA House Legislation Would Relax Reporting of Medical Device Malfunctions
The House of Representatives passed a bill that would controversially increase the time medical device companies have to report malfunctions of certain higher-risk products. 

A Cautious First Step From a Bold Administration: Proposed Rule on Clinician Quality-based Payments Incorporates Some, But Not All, MedPAC Recommendations
In the Trump administration's first step in shaping the MACRA Quality Payment Program, CMS published a proposed rule that reflects the administration's desire to reduce clinician burden.


Notice & Comment Environmental Podcast
This monthly podcast covers cutting-edge issues in environmental law and keeps tabs on policy changes under the Trump administration.
Market Stabilization Regulation – Summary and Analysis
This chart from FaegreBD Consulting’s health policy specialists provides a high-level analysis of the Trump administration’s first Affordable Care Act (ACA) market-related regulation.
ACA vs. AHCA vs. BCRA: A Comparative Analysis
This chart provides a comparative analysis of the American Health Care Act (AHCA), the Affordable Care Act (ACA) and the Better Care Reconciliation Act of 2017 (BCRA) and highlights each bill’s treatment of a number of core issues.
Who’s Who in the Trump Administration
This reference guide from FaegreBD Consulting highlights the background, policy interests and government experience of all appointees and nominees to President Trump’s Cabinet.
The Replacements: The GOP's Top Plans to Replace the ACA
This chart from FaegreBD Consulting’s health care leaders provides a high-level analysis of the GOP’s top proposals to replace the Affordable Care Act (ACA).


David R. Zook, Washington, D.C.
+1 202 589 2809

Transmission of information to us via this feature does not establish an attorney-client relationship. Do not send any information that you would have treated confidentially.